GO
Loading...

Disaster du Jour & Sunshine Stocks

Friday, 12 Oct 2012 | 2:22 PM ET

Chipmaker Advanced Micro Devices is cutting fiscal Q3 revenue guidance, and NPS Pharmaceuticals is popping after the FDA issued an upbeat preview of its short bowel syndrome drug Gattex, with CNBC's Amanda Drury and Brian Sullivan.